The number of people with susceptibility test result for rifampicin in Belgium
Belgium: The number of people with susceptibility test result for rifampicin was 86.27 in 2021. ▼ Falling
Latest (2021)
86.27
Change on year
up 0.3%
World rank
81st
of 146 countries
All-time high
91.61
in 2017
All-time low
86.02
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Belgium, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Belgium is 86.27, measured in 2021.
The figure is up 0.3% on the previous year and down 5.8% over five years.
Belgium ranks 81st of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 91.61 | — |
| 2018 | 89.71 | -2.1% |
| 2019 | 88.46 | -1.4% |
| 2020 | 86.02 | -2.8% |
| 2021 | 86.27 | +0.3% |
Belgium compared with similar countries
- Belgium's 86.27 is below the median for high income countries, which is 92.6, 93% of the median. (56 countries reporting)
- Belgium's 86.27 is below the median for Europe & Central Asia, which is 93.52, 92% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 89.93 | 88.46 | 91.61 | 3 |
| 2020s | 86.15 | 86.02 | 86.27 | 2 |
Countries ranked near Belgium
- 78 Dominican Republic 87.56 compare
- 79 Switzerland 87.3 compare
- 80 Austria 86.84 compare
- 82 Netherlands 86.26 compare
- 83 Finland 86.14 compare
- 84 Zambia 85.35 compare
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Belgium?
- The number of people with susceptibility test result for rifampicin in Belgium was 86.27 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Belgium?
- The highest recorded value was 91.61 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Belgium?
- The lowest recorded value was 86.02 in 2020.
- How does Belgium rank for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 81st out of 146 countries with data for 2021.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).